Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 115 for “"NQO1"”.
-
Design, Synthesis, and Characterization of NQO1-Activatable Luminescent Probes
… human NAD(P)H: quinone oxidoreductase-1 enzyme (NQO1). Incorporating a trimethyl-locked quinone propionic acid as the trigger group, the probes Q3NNBTCy and Q3NDODCM were designed and synthesized. Being tripartite probes, these enzyme-activatable fluorescent probes are composed of a linker …
-
Improving the Efficacy and Expanding the Application of NQO1-Bioactivated Therapeutics
NADPH:quinone oxidoreductase-1 (NQO1)-bioactivated drugs, such as ß-lapachone (ß-lap), are powerful therapeutics for tumor-specific therapy. They react with NQO1, which is highly overexpressed in most solid tumors, to cause a futile redox cycle that results in devastating oxidative DNA damage and …
-
Žmogaus DT-diaforazės (NQO1) reakcijų su chinoniniais ir nitroaromatiniais junginiais tyrimai /
… of human NAD(P)H:quinone oxidoreductase 1 (NQO1, also known as DT-diaphorase). The goal was to understand how redox potential and van der Waals volume affect reactions with quinones and nitroaromatic compounds. NQO1 plays an important role in the oxidative stress response and is known for …
-
Targeting head and neck squamous cell carcinoma through NQO1-mediated cytotoxicity
… potential in a variety of other solid tumors is NQO1-targeted therapy. In this strategy the overexpression of NQO1 can be taken advantage of by the DNQ derivative IB-DNQ which is a futile substrate for NQO1 that generates high levels of cytotoxic ROS selectively inside the cancer cell. Given the …
-
Deoxynyboquinones as NQO1-targeted anticancer compounds and deoxynybomycins as potent and selective antibiotics
Made available in DSpace on 2016-03-02T20:57:24Z (GMT). No. of bitstreams: 5 PARKINSON-DISSERTATION-2015.pdf: 21604741 bytes, checksum: 36ce90169c82a68c9b09739d5545d439 (MD5) LICENSE.txt: 4216 bytes, checksum: 30a9874759f4e96d3a10d148120d7757 (MD5) Parkinson Supplemental 1.pdf: 124148 bytes, …
-
NQO1-Bioactivatable Drugs at the Interface of Cancer Metabolism and the DNA Damage Response
… enzyme, NAD(P)H:quinone oxidoreductase-1, NQO1, is dramatically overexpressed in many solid tumor types, including pancreatic ductal adenocarcinoma (PDA) and non-small cell lung cancer (NSCLC). The Boothman laboratory has demonstrated that NQO1 bioactivates a unique class of quinones, such …
-
NAD(P)H:QUINONE OXIDOREDUCTASE (NQO1)-DIRECTED LAVENDAMYCIN ANTITUMOR AGENTS: STRUCTURE-BASED DESIGN, MOLECULAR MODELING AND STRUCTURE-ACTIVITY STUDIES
NAD(P)H:quinone oxidoreductase 1 (NQO1) is a two-electron reductase that catalyzes an NAD(P)H-dependent activation of many quinone-based antitumor agents. NQO1, expressed at high levels in many human solid tumors, can be used as a target for enzyme-directed bioreductive antitumor drug development. …
-
NAD(P)H:QUINONE OXIDOREDUCTASE (NQO1)-DIRECTED LAVENDAMYCIN ANTITUMOR AGENTS: STRUCTURE-BASED DESIGN, MOLECULAR MODELING AND STRUCTURE-ACTIVITY STUDIES
NAD(P)H:quinone oxidoreductase 1 (NQO1) is a two-electron reductase that catalyzes an NAD(P)H-dependent activation of many quinone-based antitumor agents. NQO1, expressed at high levels in many human solid tumors, can be used as a target for enzyme-directed bioreductive antitumor drug development. …
-
MECHANISMS AND CYTOTOXIC EFFECTS OF NQO1-DIRECTED LAVENDAMYCIN DERIVATIVES AND MITOCHONDRIA-TARGETED ANTHRACENYL ISOXAZOLE AMIDES AS NOVEL ANTITUMOR AGENTS
… third goal of this study was to determine the NQO1 substrate potential of a series of lavendamycin derivative quinolinequinones and assess their corresponding antitumor potential. Surprisingly, few of the quinolinequinones tested showed preferential specificity for NQO1-expressing cells …
-
MECHANISMS AND CYTOTOXIC EFFECTS OF NQO1-DIRECTED LAVENDAMYCIN DERIVATIVES AND MITOCHONDRIA-TARGETED ANTHRACENYL ISOXAZOLE AMIDES AS NOVEL ANTITUMOR AGENTS
… third goal of this study was to determine the NQO1 substrate potential of a series of lavendamycin derivative quinolinequinones and assess their corresponding antitumor potential. Surprisingly, few of the quinolinequinones tested showed preferential specificity for NQO1-expressing cells …
-
In-depth bioinformatics analysis of the phosphoproteome of triple negative breast cancer treated with a tumor selective NQO1 bioactivatable drug
… agent IB-DNQ (isobutyl-deoxyniboquinone). NQO1 or NADPH:quinone oxidoreductase-1 is a detoxifying enzyme overexpressed in many solid tumors and low expression in normal cells. IB-DNQ is bio-activated by NQO1 enzyme via a futile redox cycling, producing large amounts of reactive oxygen …
-
Developing the minipig for use in pharmacokinetic modeling : determination of microsomal and cytosolic scaling factors and validation of NQO1/NQO2 metabolism
… such as NAD(P)H Quinone Oxidoreductases (NQO1, NQO2). Herein, MPPGL (24 ± 3 mg protein/g tissue), CPPGL (76 ± 17 mg protein/g tissue), MPPGK (13 ± 4 mg protein/g tissue), CPPGK (40 ± 6 mg protein/g tissue), MPPGI (2 ± 0.7 mg protein/g tissue) and CPPGI (9 ± 0.8mg protein/g tissue) scalars …
-
The role of NAD(P)H:quinone oxidoreductase 1 in non-small cell lung cancer tumorigenesis and lung cancer stem cell maintenance
… tumorigenesis. NAD(P)H:quinone oxidoreductase 1 (NQO1) is a detoxifying enzyme that has been demonstrated to be highly overexpressed in a number of different malignancies. This overexpression has been utilized as a drug target, as the enzyme is expressed at low levels in normal tissue. To this …
-
Genpolymorphismen Arzneimittel-verstoffwechselnder Enzymsysteme bei Kindern mit Akuter Lymphoblastischer Leukämie
… Polymorphismen Cyp 3A4-v, Cyp 2D6*3, Cyp 2D6*4, NQO1 464 und NQO1 609. Für die Polymorphismen Cyp 3A4-v, NQO1 464 und NQO1 609 konnte eine Echtzeit-PCR mit dem LightCycler etabliert werden. Diese Ökonomisierung der Methodik repräsentiert einen entscheidenden Fortschritt bei …
-
Investigations on aurones as chemopreventive agents
… 2 enzyme NAD(P)H: quinone oxidoreductase 1 (NQO1). This study was motivated by: (1) the presence of a Michael acceptor motif (a common feature of many NQO1 inducing compounds) in the aurone structure, and (2) that systematic functionalization of the template may uncover derivatives with …
-
Design and Analysis of Cloaked Fluorophores for Rapid Detection and Visualization of Cancer Cells Containing NAD(P)H:Quinone Oxidoreductase-1
… tumor cells, NAD(P)H:quinone oxidoreductase-1 (NQO1). These dyes utilize the 2-electron reduction of quinones to hydroquinones, which NQO1 specifically catalyzes. A dye’s fluorescence can be quenched by conjugating a quinone directly to the fluorophore, only to have its signal uncloaked after …
-
Early growth response (Egr)-1: A novel anti-fibrotic mediator in liver
… these genes, NAD(P)H dehydrogenase, quinone 1 (Nqo1), and found that Nqo1 mRNA and protein was reduced in Egr-1 -/- mice relative to wild-type mice 72h after CCl4 exposure, and ethanol feeding exacerbated this reduction. Consistently, chromatin from livers of wild-type, CCl4-treated mice …
-
Mechanisms by which natural polyphenols regulate the expression of cytoprotective genes
… examine their effect on Nrf2 and its target gene Nqo1 in rat liver RL-34 and mouse embryonic fibroblast MEF cells. By Nqo1 enzyme activity assay, Western blotting, and Taqman experiments, our study showed that these two flavonoids increased the enzyme activity, protein expression and mRNA level of …
Page 1 of 6